[ET Net News Agency, 1 March 2024] LAEKNA-B (02105) rose 30.2% to HK$7.5.
It hits an intra-day high of HK$7.5, hitting an 1-month high, and an intra-day low of
HK$5.55. The total shares traded was 13.21 million, with a value of HK$83.38m. The active
buy/sell ratio is 56:44, with net buying turnover of HK$10.51m. GOLDMAN SACHS (ASIA) SEC
accounts for greatest net responsive buying turnover of HK$3.17m, with volume weighted
average price of HK$6.162. CHINA INNOVATION MARKET SER accounts for greatest net
responsive selling turnover of HK$3.02m, with volume weighted average price of HK$6.294.
The stock has risen a combined 107.2% over the past 3 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 7.500 % Chg +30.21%
High 7.500 Low 5.550
Shares Tr 13.21m Turnover 83.38m
10-D SMA 4.228 %H.V 202.740
20-D SMA 4.016 VWAP 6.311
50-D SMA 9.755 RSI14 60.248
----------------------------------
Status: Hitting an 1-month high, active buy/sell ratio is 56:44, with net buying turnover
of HK$10.51m, rising a combined 107.2% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
LAEKNA-B (02105) 7.50 +30.21
HUTCHMED (00013) 24.50 +1.24
GENSCRIPT BIO (01548) 15.50 -2.02
INNOVENT BIO (01801) 40.15 -5.19
EVEREST MED-B (01952) 24.60 +1.86
SIRNAOMICS-B (02257) 14.22 +11.44
WUXI BIO (02269) 19.00 -0.21
BEIGENE (06160) 99.20 -6.42
AKESO (09926) 47.60 +1.06
REMEGEN (09995) 22.55 +0.22
---------------------------------------------
(ed)